Medicines in Development for DiabetesA chart is presented depicting the development of medicines addressing diabetes including diabetes-related conditions, unspecified diabetes and type 2 diabetes.Applied Clinical Trials
For CHF patients with type 2 diabetes, LZD markedly decreased blood glucose, glycosylated hemoglobin, fasting insulin, and indices of triglyceride and total cholesterol. By enhancing glycometabolism, LZD, as a therapy for CHF with diabetes and obesity, has favorable elimination effects on risk ...
Patients prescribed at least one oral medication for type 2 diabetes and/or lipid regulation were eligible to participate. 677 patients of a mail-order pharmacy were recruited and randomised (340 intervention, 337 control). The intervention comprised two tailored telephone consultations with a ...
Diabetes is one of the largest public health concerns worldwide, with the prevalence of type 1 and type 2 diabetes projected to more than double by the yea... E Potocka - Dissertations & Theses - Gradworks 被引量: 0发表: 2009年 Editorial Strides made in asthma research in recent years al...
Skip to main content Search
View PDF Search ScienceDirect Outline Highlights ABSTRACT Keywords INTRODUCTION METHODS RESULTS DISCUSSION CONCLUSIONS AND IMPLICATIONS Declaration of Sources of Funding Declaration of Competing Interest Appendix A. Supplementary data REFERENCESShow full outline Figures (2) Tables (1) Table 1 Extras (1) ...
Non-alcoholic fatty liver disease (NAFLD) is a common liver disease that may progress into, in the absence of proper treatment, severe liver damage. While the optimal pharmacotherapy for NAFLD remains uncertain and the adherence to lifestyle intervention
Supplement 2. eAppendix 1. Essential Medicines Provided to Patients With Free Distribution eAppendix 2. Criteria for Potentially Inappropriate Prescriptions eTable 1. Alternative Definitions of Primary Outcome Results Table eTable 2. Patient Oriented Outcome Results Table Supplement 3. Data Sharing Stateme...
Type 2 diabetes is characterised by reduced sensitivity to the action of insulin (insulin resistance) and gives rise to an increase in actual insulin levels in the body in an attempt to compensate for this deficiency and to a consequent increase in glucose levels. Numerous reports have confirmed...
A prospective study reported some risk factors for AD like increasing age, low educational level, and APOE4 allele [16]. Deficiency of cholinergic mechanism has been found to be associated in the cognitive and behavioural manifestations of AD [17,18]. Cardiovasc...